Evidence map›Paper›PMID 38618495›Full record

ReviewKidney international supplements2024

Capacity for the management of kidney failure in the International Society of Nephrology South Asia region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).

Eranga Wijewickrama, Muhammad Rafiqul Alam, Divya Bajpai, Smita Divyaveer, Arpana Iyengar, Vivek Kumar, Ahad Qayyum, Shankar Prasad Yadav, Manjusha Yadla, Silvia Arruebo and 15 more

Open access · greenAbstract readReview
In one paragraph

Review in Kidney international supplements, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 17 institutions in 10 countries.

Eranga WijewickramaDepartment of Clinical Medicine, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
Muhammad Rafiqul AlamDepartment of Nephrology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
Divya BajpaiDepartment of Nephrology, Seth Gordhandas Sunderdas Medical College and King Edward Memorial Hospital, Mumbai, India.
Smita DivyaveerDepartment of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Arpana IyengarDepartment of Paediatric Nephrology, St. John's National Academy of Health Sciences, Bangalore, India.
Vivek KumarDepartment of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Ahad QayyumDepartment of Nephrology and Transplantation, Bahria Town International Hospital, Lahore, Punjab, Pakistan.
Shankar Prasad YadavDepartment of Pediatrics, B. P. Koirala Institute of Health Sciences, Dharan, Nepal.
Manjusha YadlaDepartment of Nephrology, Gandhi Medical College, Hyderabad, India.
Silvia ArrueboThe International Society of Nephrology, Brussels, Belgium.
Aminu K BelloDivision of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Fergus J CaskeyPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Sandrine DamsterThe International Society of Nephrology, Brussels, Belgium.
Jo-Ann DonnerThe International Society of Nephrology, Brussels, Belgium.
Vivekanand JhaGeorge Institute for Global Health, University of New South Wales, New Delhi, India.
David W JohnsonDepartment of Kidney and Transplant Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Adeera LevinDivision of Nephrology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Charu MalikThe International Society of Nephrology, Brussels, Belgium.
Masaomi NangakuDivision of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Ikechi G OkpechiDivision of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Marcello TonelliDepartment of Medicine, University of Calgary, Calgary, Alberta, Canada.
Feng YeDivision of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Dibya Singh ShahDepartment of Nephrology and Transplant Medicine, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal.
Narayan PrasadDepartment of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Science, Lucknow, India.
Regional Board and ISN-GKHA Team Authors
University of Alberta · CAPost Graduate Institute of Medical Education and Research · INBangladesh Medical University · BDB.P. Koirala Institute of Health Sciences · NPGandhi Medical College & Hospital · INKing Edward Memorial Hospital and Seth G.S. Medical College · INManipal Academy of Higher Education · INNational Hospital of Sri Lanka · LKSanjay Gandhi Post Graduate Institute of Medical Sciences · INShifa International Hospital · PKSt. John's National Academy of Health Sciences · INThe University of Tokyo · JPTranslational Research Institute · AUTribhuvan University Teaching Hospital · NPUniversity of Bristol · GBUniversity of British Columbia · CAUniversity of Calgary · CA

Funding

DBT-Wellcome Trust India Alliance IA/CPHI/18/1/503954DBT-Wellcome Trust India Alliance IA/CPHS/22/1/506541
6 · The paper itself

Abstract

The South Asia region is facing a high burden of chronic kidney disease (CKD) with limited health resources and low expenditure on health care. In addition to the burden of CKD and kidney failure from traditional risk factors, CKD of unknown etiologies from India and Sri Lanka compounds the challenges of optimal management of CKD in the region. From the third edition of the International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA), we present the status of CKD burden, infrastructure, funding, resources, and health care personnel using the World Health Organization's building blocks for health systems in the ISN South Asia region. The poor status of the public health care system and low health care expenditure resulted in high out-of-pocket expenditures for people with kidney disease, which further compounded the situation. There is insufficient country capacity across the region to provide kidney replacement therapies to cover the burden. The infrastructure was also not uniformly distributed among the countries in the region. There were no chronic hemodialysis centers in Afghanistan, and peritoneal dialysis services were only available in Bangladesh, India, Nepal, Pakistan, and Sri Lanka. Kidney transplantation was not available in Afghanistan, Bhutan, and Maldives. Conservative kidney management was reported as available in 63% (n = 5) of the countries, yet no country reported availability of the core CKM care components. There was a high hospitalization rate and early mortality because of inadequate kidney care. The lack of national registries and actual disease burden estimates reported in the region prevent policymakers' attention to CKD as an important cause of morbidity and mortality. Data from the 2023 ISN-GKHA, although with some limitations, may be used for advocacy and improving CKD care in the region.

Indexed as

epidemiologyGlobal Kidney Health AtlasInternational Society of Nephrologykidney failurekidney replacement therapySouth Asia

Identifiers

PMID38618495
PMCPMC11010620
OpenAlexW4394580052

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.